SPC manufacturing waiver is good news for Europe

An SPC manufacturing waiver should be extremely beneficial for Europe and will increase net sales of the EU pharmaceutical industry…

The Supplementary Protection Certificate (SPC) manufacturing… 1 July 2022 Today the transitional period for the application of the Supplementary…
Court decision on Supplementary Protection Certificate (SPC)… 18 January 2024 Medicines for Europe and its members are strongly concerned by…
Review of the SPC Manufacturing Waiver: a First Industry… 13 June 2023 The Supplementary Protection Certificate (SPC) is a sui generis protection…
Joint statement Association for Accessible Medicines -… 26 January 2024 Medicines for Europe and its members are strongly concerned by…